Bladder cancer is a serious disease that begins in the lining of the bladder, the organ that stores urine. When the cancer ...
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for ...
Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...
Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...
A non-invasive, high-accuracy surveillance test for bladder cancer has the potential to improve patient experience, streamline workflows, and reduce overall cost of care” — Megann Vaughn Watters, Vice ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
New research indicates that about one-quarter of patients with bladder cancer treated with radical surgery on curative intent have detectable levels of tumour cells circulating in their blood. The ...
Randomized study aims to reduce treatment burden for patients and utilizes Signatera to monitor for disease recurrence AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA) (NASDAQ: NTRA), a global ...
Woman's World on MSN
Doctors reveal the sneaky early cancer symptoms women often miss
Cancer specialists say it's not at all uncommon to overlook or dismiss early warning signs of several common cancers, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results